A detailed history of Charles Schwab Investment Management Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,265,981 shares of IBRX stock, worth $3.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,265,981
Previous 1,236,316 2.4%
Holding current value
$3.33 Million
Previous $7.81 Million 39.9%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.32 - $6.7 $98,487 - $198,755
29,665 Added 2.4%
1,265,981 $4.7 Million
Q2 2024

Aug 12, 2024

BUY
$4.82 - $9.15 $313,801 - $595,701
65,104 Added 5.56%
1,236,316 $7.81 Million
Q1 2024

May 08, 2024

BUY
$3.23 - $6.17 $91,367 - $174,530
28,287 Added 2.47%
1,171,212 $6.29 Million
Q4 2023

Feb 06, 2024

BUY
$1.25 - $5.21 $116,238 - $484,483
92,991 Added 8.86%
1,142,925 $5.74 Million
Q3 2023

Nov 08, 2023

BUY
$1.29 - $3.1 $92,089 - $221,299
71,387 Added 7.3%
1,049,934 $1.77 Million
Q2 2023

Aug 09, 2023

BUY
$1.53 - $6.41 $402,255 - $1.69 Million
262,912 Added 36.74%
978,547 $2.72 Million
Q1 2023

May 11, 2023

SELL
$1.35 - $4.78 $10,643 - $37,685
-7,884 Reduced 1.09%
715,635 $1.3 Million
Q4 2022

Feb 13, 2023

BUY
$4.35 - $6.77 $49,159 - $76,507
11,301 Added 1.59%
723,519 $3.67 Million
Q3 2022

Nov 14, 2022

BUY
$3.65 - $6.43 $868,510 - $1.53 Million
237,948 Added 50.17%
712,218 $3.54 Million
Q2 2022

Aug 15, 2022

SELL
$2.68 - $6.14 $50,354 - $115,364
-18,789 Reduced 3.81%
474,270 $1.77 Million
Q1 2022

May 13, 2022

BUY
$5.05 - $7.53 $84,193 - $125,540
16,672 Added 3.5%
493,059 $2.77 Million
Q4 2021

Feb 11, 2022

BUY
$5.67 - $10.18 $103,091 - $185,092
18,182 Added 3.97%
476,387 $2.9 Million
Q3 2021

Nov 16, 2021

SELL
$9.17 - $14.24 $308,607 - $479,232
-33,654 Reduced 6.84%
458,205 $4.46 Million
Q2 2021

Aug 16, 2021

BUY
$13.41 - $22.4 $3.15 Million - $5.26 Million
234,631 Added 91.22%
491,859 $7.02 Million
Q1 2021

May 17, 2021

BUY
$12.83 - $42.25 $3.3 Million - $10.9 Million
257,228 New
257,228 $6.11 Million

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.05B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.